‘Revolutionary’ pain treatment

Font Size:

One in five Australians – 4.9 million people – suffers from migraine, according to Painaustralia, and the condition is deemed to be underdiagnosed.

The pain advocacy body puts the economic cost at a whopping $35.7 billion – $14.3 billion in health system costs, $16.3 billion in productivity costs and $5.1 billion in other costs.

Despite the massive cost to the country, a Migraine in Australia Whitepaper – produced by Deloitte for pharmaceutical company Novartis – says funding for migraine research is “clearly inadequate”.

But … a new class of migraine preventative drugs is offering life-changing treatment, according to a report published in the Medical Journal of Australia (MJA) this week.

Monash Medical Centre neurologist Dr Michael Eller says the new drugs give hope to patients who have not been able to find relief from other treatments.

“I’ve got many patients who have had significant benefit from it who have been burdened from awful headaches for decades,” he said.

Dr Eller described the drugs as “revolutionary” as they specifically targeted migraines.

In a case study reported in The Age and The Sydney Morning Herald, a sufferer said she had experienced severe migraines almost every day after her thyroid had been removed when she was 32.

Over the next 12 years, she had systematically tried every treatment but without success.

“I tried every medication available, from the most common ones going towards the alternative treatments, and just nothing helped,” she said.

Then she tried one of the new migraine drugs, known by their scientific name, erenumab.

“It was pretty much a very quick improvement,” she said. “Within maybe two weeks, my migraines became less severe and they also gradually decreased.”

The controlled trial reported in the MJA found that about 50 per cent of patients taking erenumab experienced half as many migraine days per month as the placebo group.

Erenumab has been available in Australia since October 2018, and two more drugs – galcanezumab and fremanezumab – have been available since the end of 2019. None are listed on the Pharmaceutical Benefits Scheme (PBS) and the average monthly cost of treatment ranges from about $300 to $850.

The Deloitte whitepaper says a migraine is characterised by recurrent attacks of moderate to severe headache.

“Migraine pain is typically pulsating, affecting one side or area of the head. During a migraine attack, patients may experience nausea, vomiting and sensory sensitivity such as phonophobia and photophobia that significantly affects their lives,” it says.

Neurologist Dr Alexis Selby said traditional medicines used to treat migraines had been designed for other purposes.

“We have older types of antidepressant drugs which are still commonly used and often extremely effective, but will have various different side effects, as well as other things like beta blockers, anti-seizure type medications, which can for some be a very good treatment,” she said.

The new drugs have comparatively mild side effects.

“It’s really been a very good treatment, but they’re certainly not appropriate or effective for everybody,” Dr Selby said.

“It’s really important we get an understanding that there are so many different treatment options, and a huge part of the battle is getting people to see a neurologist.

“It’s a real condition and we do have real treatments which are often incredibly effective if we can find the right therapy for you.”

She stressed that non-medical therapies also played a crucial role in migraine management and treatment.

Do you or someone close to you suffer from migraines? Has it wreaked havoc with your life? Were you aware of this range of drugs?

If you enjoy our content, don’t keep it to yourself. Share our free eNews with your friends and encourage them to sign up.

RELATED LINKS

If Dr Google's making you sick with worry, there's help

If Dr Google is making you sick with worry, there is help available.

Is this the future for dementia care?

Families are sending their relatives with dementia to Thailand for treatment and care.

What you need to know about bone health

When was the last time you checked on the health of your bones? Here's why you should ask your

Written by Janelle Ward



SPONSORED LINKS

Sign-up to the YourLifeChoices Enewsletter

continue reading

COVID-19

Another vaccine ruled out as second blood clot case emerges

Australia's Therapeutic Goods Association (TGA) has announced that a second case of blood clots is believed to be linked to...

Superannuation News

Super funds fight for changes to reforms

Your Super, Your Future legislation will be enacted within three months and leading players are weighing in on the impact...

Finance

Ambulance costs around Australia

There should be no hesitation when you have to call an ambulance in an emergency situation, but some people rushed...

News

Four tell-tale signs that you may have a blood clot

A blood clot is a clump of cells and protein in your blood. Blood clots form to slow down bleeding...

Beef

Sweet Potato and Shredded Beef Bowl

When it comes to serving a lot of people, chilli is a miracle dish. You throw all the ingredients into...

Finance News

How much you can save on electricity in your home state

As we prepare to head into the colder winter months, there is good news for those worried about heating costs...

COVID-19

What is thrombocytopenia, and why did it stop the AstraZeneca jab?

Anthony Zulli, Victoria University; Maja Husaric, Victoria University; Maximilian de Courten, Victoria University, and Vasso Apostolopoulos, Victoria University Australia's medical...

Wellbeing

Ways to manage death anxiety

Winston Churchill once said: "Any man who says he is not afraid of death is a liar." But while it's...

LOADING MORE ARTICLE...